2
12
3
4

 

>
CASE STUDY 1
Parenteral dosage form development of a highly insoluble molecule
>
CASE STUDY 2
Salt form optimization and lyophilized parenteral formulation development
>
CASE STUDY 3
Oral liquid formulation development
>
CASE STUDY 4
Accelerated stability studies to support a screening IND
>
CASE STUDY 5
Lead Optimization: Solubility and formulation screen for efficacy and PK studies

 

Wolfe Laboratories to expand, relocate in Watertown

Wolfe Laboratories Inc. will relocate and expand its headquarters to accommodate rapid growth, the biopharmaceutical company said in a press release. Wolfe Laboratories will move into its new 21,000-square-foot headquarters at 134 Coolidge Ave. in Watertown next week, tripling its lab space and doubling the total office space the company occupies. Click here to read a complete article.


 

© 2004 Wolfe Laboratories, Inc. All rights reserved.